|
WDR45L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.245000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.242810E-01 |
| Normal-vs-Stage2 |
3.195600E-01 |
| Normal-vs-Stage3 |
5.258400E-01 |
| Normal-vs-Stage4 |
5.114000E-01 |
| Stage1-vs-Stage2 |
9.701000E-01 |
| Stage1-vs-Stage3 |
6.890800E-01 |
| Stage1-vs-Stage4 |
1.241020E-01 |
| Stage2-vs-Stage3 |
7.860800E-01 |
| Stage2-vs-Stage4 |
2.197800E-01 |
| Stage3-vs-Stage4 |
2.807200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.542200E-01 |
| Normal-vs-AfricanAmerican |
5.442200E-02 |
| Normal-vs-Asian |
3.436800E-01 |
| Caucasian-vs-AfricanAmerican |
1.037360E-01 |
| Caucasian-vs-Asian |
6.272800E-01 |
| AfricanAmerican-vs-Asian |
9.350200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.524950E-01 |
| Normal-vs-Female |
4.235200E-01 |
| Male-vs-Female |
3.124400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.501210E-01 |
| Normal-vs-Extreme_Weight |
1.710210E-01 |
| Normal-vs-Obese |
3.745600E-01 |
| Normal-vs-Extreme_Obese |
4.600400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.151000E-01 |
| Normal_Weight-vs-Obese |
5.363200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.806200E-01 |
| Extreme_Weight-vs-Obese |
6.664800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.155800E-01 |
| Obese-vs-Extreme_Obese |
7.372200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.200200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.349800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.103700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.020100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.162040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.405650E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.183900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.361700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.497800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.252400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.395800E-01 |
| Normal-VS-Type2 PRCC |
1.486780E-01 |
| Normal-VS-KIRP CIMP |
1.528020E-01 |
| Normal-VS-Unclassified PRCC |
9.843800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.091400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.229700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.832400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.232100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.749200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.111990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.974500E-02 |
| Normal-vs-N1 |
6.069400E-01 |
| Normal-vs-N2 |
3.349000E-01 |
| N0-vs-N1 |
5.799900E-02 |
| N0-vs-N2 |
2.295200E-01 |
| N1-vs-N2 |
1.950750E-01 |
|
|
